Tag Archives: JNJ

Quick Highlights of Most Active Stocks: Sodastream, Synta, Zynga, Cracker Barrel, Affymax, Hospira, Johnson

Posted on June 4, 2013 by Thomas Vedder

Sodastream International Ltd (NASDAQ:SODA) is still being disrespected in spite of stock lifting strongly current year to retrace much of mid-2011’s tumble, Barclays reports, boosting its EPS views for the firm through 2014 and hiking its price target to $100 …

Posted in Latest Headlines, Services | Tagged AFFY, Affymax, CBRL, Cracker Barrel, Hospira, HSP, JNJ, Johnson, NASDAQ:AFFY, NASDAQ:CBRL, NASDAQ:SNTA, NASDAQ:SODA, NASDAQ:ZNGA, NYSE:HSP, NYSE:JNJ, SNTA, SODA, Sodastream, Synta, ZNGA, Zynga | Comments Off

Healthcare Giant News Buzz: Actavis (NYSE:ACT), Warner Chilcott (NASDAQ:WCRX) – ACT, WCRX, JNJ, THRX, HALO, PPHM, MYL

Posted on May 21, 2013 by Thomas Vedder

Investors responded negatively to the healthcare stocks on Monday. Key movement were observed in Theravance Inc (NASDAQ:THRX) and Halozyme Therapeutics, Inc (NASDAQ:HALO) on percentage decliners side while Peregrine Pharmaceuticals (NASDAQ:PPHM) was prominent stock on percentage gainer side.

The Parsippany, New …

Posted in Healthcare, Latest Headlines | Tagged ACT, Actavis, HALO, Halozyme Therapeutics, JNJ, Johnson, MYL, Mylan, NASDAQ:HALO, NASDAQ:MYL, NASDAQ:PPHM, NASDAQ:THRX, NASDAQ:WCRX, NYSE:ACT, NYSE:JNJ, Peregrine Pharmaceuticals, PPHM, Theravance, THRX, Warner Chilcott, WCRX | Comments Off

Healthcare Sector Highlights: Bristol Myers Squibb (NYSE:BMY), Vermillion (NASDAQ: VRML) – BMY, VRML, JNJ, QCOR, BCR, MNKD, UNIS

Posted on May 16, 2013 by Thomas Vedder

Healthcare sector finished positively on Wednesday’s trading session end and sector hiked +0.15%. If we consider key movers of this sector so Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) were major percentage decliners while key percentage gainers were …

Posted in Healthcare, Latest Headlines | Tagged BCR, BioCryst, BMY, Bristol-Myers Squibb, JNJ, Johnson, MannKind, MNKD, NASDAQ:BCR, NASDAQ:MNKD, NASDAQ:QCOR, NASDAQ:UNIS, NASDAQ:VRML, NYSE:BMY, NYSE:JNJ, QCOR, Questcor, Unilife, UNIS, Vermillion, VRML | Comments Off

BioTime (NYSE:BTX) Net Loss Widens in Fiscal First Quarter – BTX, HSP, JNJ, CYTX

Posted on May 13, 2013 by Thomas Vedder

The Alameda, California based BioTime, Inc (NYSEMKT:BTX) announced on Friday that net loss for fiscal Q1 was $7.7 million or $0.15 a share, evaluated against a net loss of $5.0 million or $0.10 a share for same period a year …

Posted in Healthcare, Latest Headlines | Tagged BioTime, BTX, Cytori Therapeutics, CYTX, Hospira, HSP, JNJ, Johnson, NASDAQ:CYTX, NYSE:BTX, NYSE:HSP, NYSE:JNJ | Comments Off

WebMD Health (NASDAQ:WBMD) Chief Executive to Step Down; Quarterly Loss Narrows

Posted on May 8, 2013 by Thomas Vedder

WebMD Health Corp (NASDAQ:WBMD) declared fiscal Q1 loss narrowed as the company reported revenue expansion and lower expenses. The health-information provider also announced its chief executive officer is departing.

Shares of the New York based company surged 7.8 percent to …

Posted in Main Post, Technology | Tagged GOOG, Google, JNJ, Johnson, nasdaq:goog, NASDAQ:WBMD, NASDAQ:YHOO, NYSE:JNJ, WBMD, WebMD Health, Yahoo, YHOO | Comments Off

Healthcare Sector Roundup: Hologic (NASDAQ:HOLX), Insulet (NASDAQ:PODD) – HOLX, PODD, JNJ, AVEO, CYTK, GALE

Posted on May 7, 2013 by Thomas Vedder

Investors responded negatively to the healthcare stocks on Monday. Key movement were observed in AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) and Cytokinetics, Inc (NASDAQ:CYTK) on percentage gainers side while Galena Biopharma Inc (NASDAQ:GALE) was prominent stock on percentage gainer side.

Hologic, Inc …

Posted in Healthcare, Latest Headlines | Tagged AVEO, AVEO Pharmaceuticals, CYTK, Cytokinetics, GALE, Galena Biopharma, Hologic, HOLX, Insulet, JNJ, Johnson, NASDAQ:AVEO, NASDAQ:CYTK, NASDAQ:GALE, NASDAQ:HOLX, NASDAQ:PODD, NYSE:JNJ, PODD | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.